- Service Name
oncomed
- Industry
Pharmaceutical, Contract Development and Manufacturing, Oncology, Aseptic Processing
- Main Value Proposition
oncomed provides high-quality cytostatic injections and advanced manufacturing solutions tailored to the needs of pharmaceutical companies, ensuring timely and effective treatment options for cancer patients.
- Description
oncomed is a Contract Development and Manufacturing Organization (CDMO) specializing in the aseptic processing of oncology injectables. The company delivers high-potent and cytotoxic drugs worldwide to combat cancer.
- Key Features
Specialization in aseptic processing of oncology injectables; Access to free manufacturing capacity with two operational lines; Flexible and affordable outsourcing services; State-of-the-art technology for advanced drug solutions
- Use Cases
oncomed is most valuable in scenarios where pharmaceutical companies require reliable contract manufacturing for oncology injectables, need to mitigate supply risks, or seek advanced solutions for high-potent drug formulations.
- Competitive advantages
Expertise in handling high-potent APIs and sensitive materials; Commitment to social responsibility and ethical practices; Transparent service offerings that minimize additional investments
- Strengths
oncomed's strengths include its specialized knowledge in oncology, commitment to quality and safety, and the ability to provide rapid and flexible manufacturing solutions that meet the specific needs of clients.
- Positioning
oncomed positions itself as a leader in the CDMO space, particularly for oncology injectables, emphasizing its technological excellence and commitment to supporting clients in their drug development efforts.
- Audience
The target users include pharmaceutical companies, particularly those focused on oncology, healthcare providers, and organizations seeking contract manufacturing services for high-potent drugs.
- CTA
learn more
- Tags
oncology
CDMO
cytostatic injections
pharmaceutical manufacturing
- Tagline
where courage meets knowledge
- Tone of Voice
professional, supportive, innovative
- Differentiation
oncomed stands out in the market by offering a combination of specialized knowledge, flexible approaches, and state-of-the-art technology, enabling clients to pursue innovative drug solutions without significant additional investments.
- Brand Positioning
oncomed, as a subsidiary of medac GmbH, aligns itself with a mission to provide high-quality therapeutic agents for oncological diseases, reinforcing its identity as a trusted partner in the pharmaceutical industry.
- Founded
2010-01-01